HRT Financial reports disposal of $1.18 million in bioAffinity Technologies common shares
BIAF•HRT Financial reported beneficial ownership of 116,658 bioAffinity Technologies common shares after Oct. 1 transactions that included sales of 41,529 shares and purchases of 17,873 shares.
1. Share transactions
On Oct. 1, HRT Financial sold 41,529 bioAffinity Technologies common shares at a weighted average price of $6.4466 each and bought 17,873 shares at a weighted average price of $6.5436 each. It reported beneficial ownership of 116,658 shares following the transactions.




